Stockscreener 앱 받기
295.70
0.52%
1.53
전일 마감가:
$294.17
열려 있는:
$296.08
하루 거래량:
574.66K
Relative Volume:
0.88
시가총액:
$20.80B
수익:
$2.36B
순이익/손실:
$236.10M
주가수익비율:
89.99
EPS:
3.286
순현금흐름:
$382.50M
1주 성능:
-2.89%
1개월 성능:
-12.21%
6개월 성능:
-2.61%
1년 성능:
+8.82%
1일 변동 폭
$293.51
$297.48
1주일 범위
$290.98
$306.04
52주 변동 폭
$230.05
$354.88
인슐렛 코퍼레이션 Stock (PODD) Company Profile
명칭
Insulet Corporation
전화
978-600-7000
주소
100 NAGOG PARK, ACTON, MA
PODD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
295.70 | 20.69B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
인슐렛 코퍼레이션 Stock (PODD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-19 | 업그레이드 | UBS | Neutral → Buy |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 재개 | Oppenheimer | Outperform |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-05-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 개시 | RBC Capital Mkts | Outperform |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-07 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-08-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-07-28 | 개시 | Wells Fargo | Overweight |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 개시 | BofA/Merrill | Neutral |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-10 | 개시 | CFRA | Sell |
| 2019-10-23 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-10-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-10-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-06-10 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-04-20 | 개시 | Berenberg | Buy |
| 2018-02-22 | 재확인 | Barclays | Overweight |
| 2018-01-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 개시 | Barclays | Overweight |
모두보기
인슐렛 코퍼레이션 주식(PODD)의 최신 뉴스
Munro Partners Purchases Shares of 14,355 Insulet Corporation $PODD - MarketBeat
Castleark Management LLC Takes Position in Insulet Corporation $PODD - MarketBeat
Engineers Gate Manager LP Acquires 96,272 Shares of Insulet Corporation $PODD - MarketBeat
Bellevue Group AG Cuts Holdings in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Purchased by Occudo Quantitative Strategies LP - MarketBeat
Bayesian Capital Management LP Invests $3.90 Million in Insulet Corporation $PODD - MarketBeat
A Look Into Insulet Inc's Price Over Earnings - Benzinga
WINTON GROUP Ltd Has $1.27 Million Holdings in Insulet Corporation $PODD - MarketBeat
418,356 Shares in Insulet Corporation $PODD Purchased by Qube Research & Technologies Ltd - MarketBeat
Ossiam Sells 6,988 Shares of Insulet Corporation $PODD - MarketBeat
(PODD) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Insulet Corporation $PODD Shares Bought by California Public Employees Retirement System - MarketBeat
Here is Why Growth Investors Should Buy Insulet (PODD) Now - sharewise.com
Natixis Acquires Shares of 27,563 Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Bought by First Trust Advisors LP - MarketBeat
Insider Buying: Timothy Stonesifer Acquires Shares of Insulet Co - GuruFocus
Insulet Corp. stock underperforms Monday when compared to competitors - MarketWatch
Insulet Corp Director Timothy C. Stonesifer Buys 962 Shares - TradingView
Insulet Insider Bought Shares Worth $299,884, According to a Recent SEC Filing - marketscreener.com
Insulet : Appoints Cristal Downing to Newly Created Role of Chief Corporate Affairs Officer - marketscreener.com
PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements - TradingView — Track All Markets
Insulet Corporation $PODD Shares Sold by Brown Advisory Inc. - MarketBeat
Patient Monitoring Stocks Q3 In Review: Insulet (NASDAQ:PODD) Vs Peers - Finviz
Insulet (NASDAQ:PODD) Shareholders YoY Returns Are Lagging the Company's 8.5% Five-year Earnings Growth - 富途牛牛
Federated Hermes Inc. Grows Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Purchased by Jump Financial LLC - MarketBeat
FDA clears Insulet’s Omnipod 5 algorithm enhancements - MSN
Insulet gets FDA clearance for updates to Omnipod 5 automated insulin delivery - MSN
Insulet Corporation: Inside the Strategy Driving Its Robust Type 2 Adoption! - Smartkarma
Assessing Insulet’s Valuation After Omnipod Expansion and Recent Share Price Volatility - Yahoo Finance
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
FDA Clearance Of Lower-Target Omnipod 5 Upgrade Could Be A Game Changer For Insulet (PODD) - simplywall.st
Insulet Announces FDA 510(k) Clearance of Omnipod 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - marketscreener.com
Marshall Wace LLP Boosts Position in Insulet Corporation $PODD - MarketBeat
Baird Financial Group Inc. Reduces Stock Holdings in Insulet Corporation $PODD - MarketBeat
FDA clears Insulet’s enhanced Omnipod 5 insulin delivery system By Investing.com - Investing.com South Africa
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Here's Why Insulet (PODD) is a Strong Growth Stock - sharewise.com
Insulet stock price target maintained at $379 by TD Cowen on FDA clearance - Investing.com Nigeria
FDA Clears Omnipod 5 Algorithm Updates, Adding 100 mg/dL Target Glucose Option - Patient Care Online
FDA OKs Algorithm Updates to Insulet’s Omnipod 5 Insulin Pump - Medical Product Outsourcing
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - BioSpace
Insulet announces FDA 510(k) clearance of Omnipod 5 algorithm enhancements - marketscreener.com
TD Cowen Reiterates Buy Rating on Insulet Corporation (PODD) - StreetInsider
Insulet Announces FDA 510(K) Clearance Of Omnipod 5 Algorithm Enhancements - TradingView
Insulet Wins FDA Clearance for Updated Omnipod 5 Algorithm - marketscreener.com
Insulet (PODD) Gains FDA Clearance for Omnipod 5 System Updates - GuruFocus
FDA clears Insulet’s enhanced Omnipod 5 insulin delivery system - Investing.com
Insulet wins FDA clearance for Omnipod 5 algorithm enhancements - MassDevice
Is Insulet Corporation (GOV) stock attractive post correctionMarket Risk Summary & Technical Pattern Based Signals - Newser
Fisher Asset Management LLC Trims Position in Insulet Corporation $PODD - MarketBeat
인슐렛 코퍼레이션 (PODD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
자본화:
|
볼륨(24시간):